Back to results
US 10,696,996 B2Granted
Biosynthesis of everninomicin analogs in Micromonospora carbonacea var aurantiaca
AssigneeVanderbilt Univeristy
InventorsBrian O. Bachmann, Emilianne M. Limbrick, Kasia Derewacz
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of preparing everninomicin analogs by genetic alteration of Micromonospora carbonacea. Everninomicin analogs prepared by these methods and methods of using these analogs to treat infections are also disclosed.
Claims4
A compound having the structure:
- wherein
- R5-R6 are each, individually, H, OH, OCH3, CH2OH, CHO, CO2H, CO2R12, C(O)R12, or C1-C6 alkyl;
- R7 is H or CH3;
- R8 is H, OCH3, CH2OH, CO2H, CO2R12, C(O)R12, or substituted C1-C6 alkyl that is substituted with alkyl, alkoxy, halide, or hydroxy;
- R9 is H, OH, OCH3, or C1-C6 alkyl;
- each R11 is, independently, H, OCH3, C1-C6 alkyl, or a 1-20 atom linker bound to rosaramicin;
- and
- R12 is C1-C6 alkyl,
- or a pharmaceutically acceptable salt thereof, wherein the compound is not
6 more elements
Dependencies are inferred from the claim text.